martes, 6 de octubre de 2026
BuscarExplore
Via News Knowledge File

NASDAQ

organization100% conf.·synced Oct 6, 2026

Stock exchange where Jayud is listed

14
sourced metrics
1654
relationships
5
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Recovery Time From Prior Peak
15years
Stock Price
91.14USD
Index Level
23548.88points
Weekly Return
6percent
Listed Companies
3500companies
Index Change
-1percent
Minimum Bid Price
1.00USD
Market Return
185percent
Apr 4, 2026source
Percent Change
-2.4percent
Mar 27, 2026source
Daily Return
-0.59percent
Mar 25, 2026source
Daily Change
1percent
Feb 25, 2026source
Return
20percent
Dec 26, 2025source
Market Cap Multiple
5times_dotcom_peak
Jan 1, 2025source
Stock Index Decline
80percent
Oct 1, 2002source

Stated objectives

Start tokenization operations

source
by 2026-01-01 00:00:00stated

Obtain approval for 23-hour weekday trading

source
target: 23 hours per weekday stated

Allow stocks to be tokenized and traded on regulated venues

source
stated

Nasdaq expanding into tokenized securities following SEC approval, aiming to bring traditional securities onto the blockchain

source
stated

Nasdaq taking steps toward listing tokenized stocks where on-chain tokens represent real-world equities

source
stated

Relationship graph · 1654 connections

listed on
1082
located in
361
regulates
59
trades on
24
headquartered in
19
Owns
14
Covered by
11
Supplies to
10

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com